27 July 2016

Written by Jill Margo - Financial Review

A landmark  Australian study has questioned the value of using expensive robotic technology to treat prostate cancer.

This is the first study in the world to present high-level evidence showing that three months after surgery, there was no significant difference in primary outcomes between men who had a robotic operation and those who had a traditional operation.

To read the full article visit here.